CCCC Stock Analysis: Buy, Sell, or Hold?
CCCC - C4 Therapeutics, Inc.
$4.18
-0.08 (-1.99%)
▼
5d:
+8.01%
30d:
+16.76%
90d:
+29.81%
WAIT
LOW Confidence
Analysis Updated: Aug 18, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When CCCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CCCC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CCCC shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CCCC is currently trading at $4.18, which is considered extended relative to its 30-day fair value range of $3.52 to $3.99.
Technical Outlook: Technically, CCCC is in a strong uptrend. Immediate support is located at $3.54, while resistance sits at $4.32.
Market Sentiment: CCCC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.33 (+219.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CCCC is in a strong uptrend. Immediate support is located at $3.54, while resistance sits at $4.32.
Market Sentiment: CCCC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.33 (+219.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.52 -
$3.99
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 219.0% below Wall St target ($13.33)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.52 -
$3.99
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.54
Resistance Level
$4.32
Current Trend
Strong Uptrend
Technical data as of
Aug 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.19
Wall Street Target
$13.33
(+219.0%)
Revenue Growth (YoY)
2.8%
Profit Margin
-289.4%
Share & Embed Analysis
Last updated: August 19, 2026 7:49 AM ET
Data refreshes hourly during market hours. Next update: 8:49 AM
Data refreshes hourly during market hours. Next update: 8:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 64 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
